About
Our Impact
During the first two measurement years of the RIZE campaign, participating groups documented or administered a total of 11,938,960 vaccines. The breakdown by measurement year and vaccine are as follows:
| Measurement Year | Influenza (19+) |
Pneumococcal (66+) | Td/Tdap (19+) |
Zoster (50+) |
Total by Measurement Year |
| 2021 (Q3 2021 – Q2 2022) |
4,370,534 | 215,311 | 712,813 | 594,490 | 5,893,148 |
| 2022 (Q3 2022 – Q2 2023) |
4,552,674 | 260,421 | 725,613 | 507,104 | 6,045,812 |
| Total by Vaccine | 8,923,208 | 475,732 | 1,438,426 | 1,101,594 | 11,938,960 |
Over the course of two measurement years, there was a three percent improvement in the bundle measure (66+ vaccinated with influenza, pneumococcal, Td/Tdap, and zoster), which equates to 105,777 additional adults receiving comprehensive immunization care.
Due to our impact on influenza vaccination rates across the country, the National Influenza Immunization Summit recognized RIZE as a National Winner of their 2023 “Influenza Season” Immunization Champion Award.